Sarah Cannon Research Institute, based in Memphis, TN, is a leading Cancer Institute of HCA Healthcare, offering integrated cancer treatments with convenient access to cutting-edge therapies for individuals facing cancer in communities across the United States and United Kingdom. Through its services, Sarah Cannon provides state-of-the-art cancer care close to home for hundreds of thousands of patients, a number unmatched by any single cancer center.
As a world leader in shaping the standard of care through new cancer drug approvals for 20 years, Sarah Cannon Research Institute provides community-based access to hundreds of clinical trials annually and boasts one of the world's largest early-phase clinical trial menus. Their personalized medicine initiatives, such as the genomics platform GenoSpace, help identify genetic mutations specific to cancer, enabling more effective therapies to be matched with patients.
Generated from the website